|
Sign In to gain access to subscriptions and/or personal tools.
|
Neoplastic Lesions of Questionable Significance to Humans
Roger H. Alison
Preclinical Safety Consultants, 7 Earning Street, Godmanchester, Huntingdon, Cambridgeshire PE18 8JD, United Kingdom
Charles C. Capen
Department of Veterinary Pathobiology, The Ohio State University, 1925 Coffey Road, Columbus, Ohio 43210
David E. Prentice
Preclinical Safety Consultants, 7 Earning Street, Godmanchester, Huntingdon, Cambridgeshire PE18 8JD, United Kingdom
Many compounds giving a positive result in animal carcinogenicity studies through mechanisms involving secondary carcinogenesis pose little or no risk to humans. This article provides an overview of current understanding, with particular reference to renal tumors in male rats with 2µ-globulin nephropathy, urinary bladder neoplasia in rodents, mesovarian leiomyomas induced in rats by β2-receptor stimulants, carcinoid tumors in the rodent stomach induced by prolonged suppression of acid secretion, thyroid follicular cell tumors in rodents, canine mammary neoplasia due to administration of progestagens, rodent mammary neoplasia induced by estrogens, uterine endometrial carcinomas of rats induced by dopamine agonists, Leydig cell tumors in the testis of rats, and ovarian tubulostromal adenomas in mice. A positive result on a rodent carcinogenicity study should not automatically preclude further development of a compound; future progress in this field should increase the accuracy of the rodent carcinogenicity study as a tool in human safety assessment.
Key Words: Secondary carcinogenesis safety assessment neoplasia kidney stomach mammary gland ovary testis
Toxicologic Pathology, Vol. 22, No. 2,
179-186 (1994)
DOI: 10.1177/019262339402200211

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Dill, K. M. Lee, R. A. Renne, R. A. Miller, A. F. Fuciarelli, K. M. Gideon, P. C. Chan, L. T. Burka, and J. H. Roycroft
{alpha}2u-Globulin Nephropathy and Carcinogenicity following Exposure to Decalin (Decahydronaphthalene) in F344/N Rats
Toxicol. Sci.,
April 1, 2003;
72(2):
223 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Long, I. R. Cohen, C. L. Gries, J. K. Young, P. C. Francis, and C. C. Capen
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator
Toxicol Pathol,
October 1, 2001;
29(6):
719 - 726.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Long, I. R. Cohen, C. L. Gries, J. K. Young, P. C. Francis, and C. C. Capen
Proliferative Lesions of Ovarian Granulosa Cells and Reversible Hormonal Changes Induced in Rats by a Selective Estrogen Receptor Modulator
Toxicol Pathol,
June 1, 2001;
29(4):
403 - 410.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Reversibility of the Chronic Effects of Di(2-ethylhexyl)phthalate
Toxicol Pathol,
June 1, 2001;
29(4):
430 - 439.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Capen
Overview of Structural and Functional Lesions in Endocrine Organs of Animals
Toxicol Pathol,
January 1, 2001;
29(1):
8 - 33.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Chronic Toxicity of Di(2-ethylhexyl)phthalate in Rats
Toxicol. Sci.,
June 1, 2000;
55(2):
433 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Lynch, D. W. Bryant, G. J. Hook, E. R. Nestmann, and I. C. Munro
Carcinogenicity of Monochloro-1,2-Propanediol ({alpha}-Chlorohydrin, 3-MCPD)
International Journal of Toxicology,
January 1, 1998;
17(1):
47 - 76.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Davies and A. Monro
Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents
International Journal of Toxicology,
April 1, 1995;
14(2):
90 - 107.
[Abstract]
[PDF]
|
 |
|
|
|